Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:27 AM
Study NCT ID:
NCT00381199
Status:
COMPLETED
Last Update Posted:
2007-05-21
First Post:
2006-09-25
Brief Title:
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
Sponsor:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Organization:
McGill University Health CentreResearch Institute of the McGill University Health Centre
Study Overview
Official Title:
Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia
Status:
COMPLETED
Status Verified Date:
2007-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Most chronic pain patients with insomnia are currently not well-managed using existing medications If found to safely improve sleep with chronic pain patients nabilone could be added to the treatment options available in the management of fibromyalgia and associated symptoms
The principle hypothesis of this study is that nabilone at a dose of 05-1mg is as efficacious as amitriptyline at a dose of 10-20mg in improving sleep quality in patients with fibromyalgia
The principle hypothesis of this study is that nabilone at a dose of 05-1mg is as efficacious as amitriptyline at a dose of 10-20mg in improving sleep quality in patients with fibromyalgia
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None